相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Role of Chitinase 3-like 1 as a Biomarker in Multiple Sclerosis A Systematic Review and Meta-analysis
Stefano Floro et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2022)
Potential Role of CHI3L1+Astrocytes in Progression in MS
Laura Cubas-Nunez et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2021)
The identification, development and therapeutic potential of IL-10-producing regulatory B cells in multiple sclerosis
Weiwei Xiang et al.
JOURNAL OF NEUROIMMUNOLOGY (2021)
The Evolution of Neurofilament Light Chain in Multiple Sclerosis
Carolina Ferreira-Atuesta et al.
FRONTIERS IN NEUROSCIENCE (2021)
CSF Chitinase 3-Like 2 Is Associated With Long-term Disability Progression in Patients With Progressive Multiple Sclerosis
Manuel Comabella et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2021)
TH17 cells require ongoing classic IL-6 receptor signaling to retain transcriptional and functional identity
Stacey N. Harbour et al.
SCIENCE IMMUNOLOGY (2020)
IL-6 in the Cerebrospinal Fluid Signals Disease Activity in Multiple Sclerosis
Mario Stampanoni Bassi et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2020)
Distinct Expression of Inflammatory Features in T Helper 17 Cells from Multiple Sclerosis Patients
Alessia Capone et al.
CELLS (2019)
Chi3l3 induces oligodendrogenesis in an experimental model of autoimmune neuroinflammation
Sarah C. Starossom et al.
NATURE COMMUNICATIONS (2019)
Intrathecal oligoclonal bands synthesis in multiple sclerosis: is it always a prognostic factor?
Jessica Frau et al.
JOURNAL OF NEUROLOGY (2018)
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
Alan J. Thompson et al.
LANCET NEUROLOGY (2018)
Delayed treatment of MS is associated with high CSF levels of IL-6 and IL-8 and worse future disease course
Mario Stampanoni Bassi et al.
JOURNAL OF NEUROLOGY (2018)
Science is 1% inspiration and 99% biomarkers
Nicolas Dubuisson et al.
MULTIPLE SCLEROSIS JOURNAL (2017)
Science is 1% inspiration and 99% biomarkers
Nicolas Dubuisson et al.
MULTIPLE SCLEROSIS JOURNAL (2017)
Outcome Measures in Clinical Trials for Multiple Sclerosis
Caspar E. P. van Munster et al.
CNS DRUGS (2017)
Cerebrospinal fluid chitinase-3-like 2 and chitotriosidase are potential prognostic biomarkers in early multiple sclerosis
M. Mollgaard et al.
EUROPEAN JOURNAL OF NEUROLOGY (2016)
Elevated CSF neurofilament proteins predict brain atrophy: A 15-year follow-up study
Axel Petzold et al.
MULTIPLE SCLEROSIS JOURNAL (2016)
Inclusion of brain volume loss in a revised measure of no evidence of disease activity' (NEDA-4) in relapsing-remitting multiple sclerosis
Ludwig Kappos et al.
MULTIPLE SCLEROSIS JOURNAL (2016)
Elevated CSF neurofilament proteins predict brain atrophy: A 15-year follow-up study
Axel Petzold et al.
MULTIPLE SCLEROSIS JOURNAL (2016)
Inclusion of brain volume loss in a revised measure of no evidence of disease activity' (NEDA-4) in relapsing-remitting multiple sclerosis
Ludwig Kappos et al.
MULTIPLE SCLEROSIS JOURNAL (2016)
Chitinase 3-like 1: prognostic biomarker in clinically isolated syndromes
Ester Canto et al.
BRAIN (2015)
Clinical significance of the number of oligoclonal bands in patients with clinically isolated syndromes
Gloria Dalla Costa et al.
JOURNAL OF NEUROIMMUNOLOGY (2015)
The prognostic value of CSF neurofilaments in multiple sclerosis at 15-year follow-up
Axel Petzold
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2015)
Advances in T Helper 17 Cell Biology: Pathogenic Role and Potential Therapy in Multiple Sclerosis
Elisabetta Volpe et al.
MEDIATORS OF INFLAMMATION (2015)
Cerebrospinal fluid levels of chitinase 3-like 1 and neurofilament light chain predict multiple sclerosis development and disability after optic neuritis
S. Modvig et al.
MULTIPLE SCLEROSIS JOURNAL (2015)
Chitinase 3-like proteins as diagnostic and prognostic biomarkers of multiple sclerosis
G. Hinsinger et al.
MULTIPLE SCLEROSIS JOURNAL (2015)
Cerebrospinal fluid levels of chitinase 3-like 1 and neurofilament light chain predict multiple sclerosis development and disability after optic neuritis
S. Modvig et al.
MULTIPLE SCLEROSIS JOURNAL (2015)
Chitinase 3-like proteins as diagnostic and prognostic biomarkers of multiple sclerosis
G. Hinsinger et al.
MULTIPLE SCLEROSIS JOURNAL (2015)
Interleukin-2 at the Crossroads of Effector Responses, Tolerance, and Immunotherapy
Wei Liao et al.
IMMUNITY (2013)
Cerebrospinal fluid oligoclonal bands in multiple sclerosis and clinically isolated syndromes: a meta-analysis of prevalence, prognosis and effect of latitude
Ruth Dobson et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2013)
SOLUBLE CD146 IN CEREBROSPINAL FLUID OF ACTIVE MULTIPLE SCLEROSIS
H. Duan et al.
NEUROSCIENCE (2013)
Characteristic Cerebrospinal Fluid Cytokine/Chemokine Profiles in Neuromyelitis Optica, Relapsing Remitting or Primary Progressive Multiple Sclerosis
Takuya Matsushita et al.
PLOS ONE (2013)
Cellular sources of dysregulated cytokines in relapsing-remitting multiple sclerosis
Jeppe Romme Christensen et al.
JOURNAL OF NEUROINFLAMMATION (2012)
Competition for IL-2 between regulatory and effector T cells to chisel immune responses
Thomas Hoefer et al.
FRONTIERS IN IMMUNOLOGY (2012)
Role of Chitin and Chitinase/Chitinase-Like Proteins in Inflammation, Tissue Remodeling, and Injury
Chun Geun Lee et al.
ANNUAL REVIEW OF PHYSIOLOGY, VOL 73 (2011)
Neurofilament heavy chain in CSF correlates with relapses and disability in multiple sclerosis
J. Kuhle et al.
NEUROLOGY (2011)
Combination of CSF N-acetylaspartate and neurofilaments in multiple sclerosis
C. E. Teunissen et al.
NEUROLOGY (2009)
A multifactorial prognostic index in multiple sclerosis - Cerebrospinal fluid IgM oligoclonal bands and clinical features to predict the evolution of the disease
Jessica Mandrioli et al.
JOURNAL OF NEUROLOGY (2008)
Lipid-specific immunoglobulin M in CSF predicts adverse long-term outcome in multiple sclerosis
M. Thangarajh et al.
MULTIPLE SCLEROSIS JOURNAL (2008)
Intrathecal IgM-synthesis does not correlate with the risk of relapse in patients with a primary demyelinating event
R. Schneider et al.
EUROPEAN JOURNAL OF NEUROLOGY (2007)
Intrathecal IgM production at clinical onset correlates with a more severe disease course in multiple sclerosis
P. Perini et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2006)
Recommended standard of cerebrospinal fluid analysis in the diagnosis of multiple sclerosis -: A consensus statement
MS Freedman et al.
ARCHIVES OF NEUROLOGY (2005)
T-cell cytokines in injury-induced neural damage and repair
M Schroeter et al.
NEUROMOLECULAR MEDICINE (2005)
Axonal damage accumulates in the progressive phase of multiple sclerosis: three year follow up study
A Petzold et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2005)
Intrathecal IgM synthesis is a prognostic factor in multiple sclerosis
LM Villar et al.
ANNALS OF NEUROLOGY (2003)
B cells regulate autoimmunity by provision of IL-10
S Fillatreau et al.
NATURE IMMUNOLOGY (2002)
Intrathecal IgM synthesis predicts the onset of new relapses and a worse disease course in MS
LM Villar et al.
NEUROLOGY (2002)
Intrathecal IgM synthesis in neurologic diseases:: Relationship with disability in MS
LM Villar et al.
NEUROLOGY (2002)
A sensitive and reproducible method for the detection of oligoclonal IgM bands
LM Villar et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2001)
Oligoclonal band number as a marker for prognosis in multiple sclerosis
JR Avasarala et al.
ARCHIVES OF NEUROLOGY (2001)
Reporting cerebrospinal fluid data: Knowledge base and interpretation software
H Reiber et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2001)
Incidence of CSF abnormalities in siblings of multiple sclerosis patients and unrelated controls
S Haghighi et al.
JOURNAL OF NEUROLOGY (2000)
分享论文
